<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>extracellular vesicles &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/extracellular-vesicles/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 17 Jan 2026 14:52:46 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>extracellular vesicles &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Revolutionary Method Enhances Proteomic Profiling of EVs</title>
		<link>https://bioengineer.org/revolutionary-method-enhances-proteomic-profiling-of-evs/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 17 Jan 2026 14:52:46 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[biomarker discovery]]></category>
		<category><![CDATA[Cerebrospinal fluid** **Seçimlerin gerekçesi:** 1. **Tetraspanin-based immunocapture:** Makalenin odak noktası olan yenilikçi yöntem. 2.]]></category>
		<category><![CDATA[extracellular vesicles]]></category>
		<category><![CDATA[İşte bu içerik için 5 uygun etiket (virgülle ayrılmış): **Tetraspanin-based immunocapture]]></category>
		<category><![CDATA[proteomic profiling]]></category>
		<guid isPermaLink="false">https://bioengineer.org/revolutionary-method-enhances-proteomic-profiling-of-evs/</guid>

					<description><![CDATA[In the ever-evolving field of proteomics, researchers are continuously seeking innovative methodologies to enhance biomarker discovery. Recent advancements have spotlighted the potential of tetraspanin-based immunocapture techniques as a novel solution for the high-depth proteomic profiling of extracellular vesicles (EVs) derived from cerebrospinal fluid (CSF). This emerging approach presents exciting opportunities to unlock the biochemical secrets [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">317772</post-id>	</item>
		<item>
		<title>Chlorella Nanogels Suppress Lung Injury Inflammation</title>
		<link>https://bioengineer.org/chlorella-nanogels-suppress-lung-injury-inflammation/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 09 Jan 2026 03:22:35 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cGAS-STING pathway]]></category>
		<category><![CDATA[Chlorella nanogels]]></category>
		<category><![CDATA[extracellular vesicles]]></category>
		<category><![CDATA[Nanomedicine]]></category>
		<category><![CDATA[Radiation-induced lung injury]]></category>
		<guid isPermaLink="false">https://bioengineer.org/chlorella-nanogels-suppress-lung-injury-inflammation/</guid>

					<description><![CDATA[In a groundbreaking advancement at the intersection of biotechnology and radiation medicine, researchers have identified a novel nanogel derived from Chlorella extracellular vesicles that demonstrates remarkable therapeutic potential against radiation-induced lung injury (RILI). Published in Nature Communications in 2026, this study by Hu, Lu, Zhang, and colleagues unveils an innovative approach targeting the cGAS-STING signaling [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">315134</post-id>	</item>
		<item>
		<title>Linking LncRNAs in EVs to Metabolic Syndrome in PCOS</title>
		<link>https://bioengineer.org/linking-lncrnas-in-evs-to-metabolic-syndrome-in-pcos/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 18 Dec 2025 04:05:03 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[extracellular vesicles]]></category>
		<category><![CDATA[LncRNAs]]></category>
		<category><![CDATA[Makalenin içeriğine ve anahtar kelimelerine göre en uygun 5 etiket: **PCOS]]></category>
		<category><![CDATA[metabolic syndrome]]></category>
		<category><![CDATA[Women's Health** **Açıklama:** 1. **PCOS:** Makalenin temel odağı Polikistik Over Sendromu olduğu için en kritik etiket. 2. **Metabolic Syndrome:** PCOS ile güç]]></category>
		<guid isPermaLink="false">https://bioengineer.org/linking-lncrnas-in-evs-to-metabolic-syndrome-in-pcos/</guid>

					<description><![CDATA[In a groundbreaking investigation uncovering the intricate relationship between plasma extracellular vesicles (EVs), long non-coding RNAs (lncRNAs), and the metabolic syndrome associated with polycystic ovary syndrome (PCOS), researchers Wu and Mao have ventured into a highly relevant area of study that intertwines reproductive health and metabolic disorder. The implications of this research extend beyond the [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">309047</post-id>	</item>
		<item>
		<title>Extracellular Vesicles: Tumor Immune Microenvironment Influence</title>
		<link>https://bioengineer.org/extracellular-vesicles-tumor-immune-microenvironment-influence/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 13 Dec 2025 10:07:57 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cancer therapy]]></category>
		<category><![CDATA[EV biogenesis]]></category>
		<category><![CDATA[extracellular vesicles]]></category>
		<category><![CDATA[immunomodulation]]></category>
		<category><![CDATA[tumor-immune microenvironment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/extracellular-vesicles-tumor-immune-microenvironment-influence/</guid>

					<description><![CDATA[Extracellular vesicles (EVs) are increasingly recognized as pivotal players in intercellular communication, particularly concerning their significant impacts on the tumor immune microenvironment. The recent research highlighted by Yeat and Chen delves into the biogenesis mechanisms of these vesicles and elucidates their roles in modulating immune responses within tumors. The intricate nature of EVs and their [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">307220</post-id>	</item>
		<item>
		<title>ARB Candesartan Shows Neuroprotection in Parkinson’s Disease</title>
		<link>https://bioengineer.org/arb-candesartan-shows-neuroprotection-in-parkinsons-disease/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 10 Dec 2025 13:18:10 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Candesartan]]></category>
		<category><![CDATA[Candesartan neuroprotection]]></category>
		<category><![CDATA[extracellular vesicles]]></category>
		<category><![CDATA[Extracellular vesicles proteomics]]></category>
		<category><![CDATA[neuroinflammation modulation]]></category>
		<category><![CDATA[Neuroprotection]]></category>
		<category><![CDATA[Neuroprotective Mechanisms]]></category>
		<category><![CDATA[Parkinson’s disease]]></category>
		<category><![CDATA[Parkinson’s disease therapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/arb-candesartan-shows-neuroprotection-in-parkinsons-disease/</guid>

					<description><![CDATA[In a groundbreaking study set to transform the landscape of Parkinson’s disease therapy, researchers have unveiled compelling evidence that the angiotensin receptor blocker (ARB) candesartan exerts profound neuroprotective effects in affected patients. Leveraging advanced proteomic analysis of extracellular vesicles (EVs) derived from brain tissue, the study elucidates the intricate molecular mechanisms underpinning this protective action, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">304975</post-id>	</item>
		<item>
		<title>TROP2 in Ascitic Vesicles Fuels Ovarian Cancer Metastasis</title>
		<link>https://bioengineer.org/trop2-in-ascitic-vesicles-fuels-ovarian-cancer-metastasis/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 26 Nov 2025 07:09:01 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Ascitic extracellular vesicles]]></category>
		<category><![CDATA[extracellular vesicles]]></category>
		<category><![CDATA[İşte 5 uygun etiket: **TROP2]]></category>
		<category><![CDATA[Mesothelial-to-mesenchymal transition]]></category>
		<category><![CDATA[ovarian cancer metastasis]]></category>
		<category><![CDATA[Peritoneal metastasis mechanisms]]></category>
		<category><![CDATA[Peritoneal Metastasis** * **TROP2:** Makalenin ana odağı olan protein. * **Extracellular Vesicles:** TROP2'nin taşındığı ve etki ettiği kritik mekanizma (ascitic vesicles). * **Ovar]]></category>
		<category><![CDATA[TROP2 in ovarian cancer]]></category>
		<category><![CDATA[Tumor microenvironment signaling]]></category>
		<guid isPermaLink="false">https://bioengineer.org/trop2-in-ascitic-vesicles-fuels-ovarian-cancer-metastasis/</guid>

					<description><![CDATA[In a groundbreaking investigation that sheds new light on the molecular mechanisms underlying ovarian cancer progression, researchers have spotlighted Trophoblast cell surface antigen 2 (TROP2) as a pivotal player in peritoneal metastasis. Conducted by a team led by Xie, Chen, and Lv, this study delves into the enigmatic role of TROP2 found in ascitic extracellular [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">301459</post-id>	</item>
		<item>
		<title>Plasma MicroRNAs Differentiate Focal Cortical Dysplasia Types</title>
		<link>https://bioengineer.org/plasma-micrornas-differentiate-focal-cortical-dysplasia-types/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 02 Nov 2025 10:09:18 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[biomarkers]]></category>
		<category><![CDATA[extracellular vesicles]]></category>
		<category><![CDATA[focal cortical dysplasia]]></category>
		<category><![CDATA[pediatric epilepsy]]></category>
		<category><![CDATA[plasma microRNAs]]></category>
		<guid isPermaLink="false">https://bioengineer.org/plasma-micrornas-differentiate-focal-cortical-dysplasia-types/</guid>

					<description><![CDATA[In a groundbreaking study poised to redefine diagnostic pathways in pediatric neurology, researchers have identified plasma extracellular vesicles-derived microRNAs as potent biomarkers for distinguishing between two subtypes of focal cortical dysplasia (FCD), a common cause of drug-resistant epilepsy in children. The study, spearheaded by Zhou, Yu, Liu, and colleagues, published in Pediatric Research, reveals a [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">290239</post-id>	</item>
		<item>
		<title>Extracellular Vesicle Proteases Reduce A-Synuclein Aggregation</title>
		<link>https://bioengineer.org/extracellular-vesicle-proteases-reduce-a-synuclein-aggregation/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 29 Sep 2025 19:10:40 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[alpha-synuclein aggregation]]></category>
		<category><![CDATA[extracellular vesicles]]></category>
		<category><![CDATA[neurodegenerative disorders]]></category>
		<category><![CDATA[Parkinson’s disease]]></category>
		<category><![CDATA[proteolytic activity]]></category>
		<guid isPermaLink="false">https://bioengineer.org/extracellular-vesicle-proteases-reduce-a-synuclein-aggregation/</guid>

					<description><![CDATA[In the relentless quest to unravel the complexities of Parkinson’s disease, a groundbreaking new study has surfaced that could reshape our understanding of how this neurodegenerative disorder progresses—and crucially, how it might be halted. Researchers have zeroed in on the protective role of extracellular vesicles (EVs), revealing their remarkable ability to degrade harmful aggregates of [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">273340</post-id>	</item>
	</channel>
</rss>
